Feasability of retroperitoneal pelvic lymph node exploration in cervical carcinoma. Assessment of morbidity in 33 cases treated by combined radio-surgery or definitive radiotherapy

被引:7
作者
Bolla, M
Salvat, J
Sarrazin, R
Dyon, JF
Berland, E
Schmidt, MH
deCornelier, J
Quoc, TDH
Rolachon, I
机构
[1] CTR HOSP,SERV GYNECOL OBSTET,F-74200 THONON LES BAINS,FRANCE
[2] CHU GRENOBLE,SERV CHIRURG GEN,F-38043 GRENOBLE,FRANCE
关键词
cervix carcinoma; endoscopic pelvic lymph node exploration; prognosis;
D O I
10.1016/0167-8140(96)01790-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purposes: Laparoscopic modalities by selective biopsies permit a better assessment of the pelvic lymph nodes status than imaging procedures in cervix carcinoma. They could enable the radiation oncologist to adapt the target volume of external irradiation, provided the feasibility of such procedures is good and the toxicity reduced as much as possible. Material and methods: From June 1980 to May 1993, 52 women with a mean age of 49, underwent a retroperitoneal pelvic lymph node laparoscopic procedure for cervix carcinoma classified according to FIGO as stages IA(2) (14), IB (12), IIA (6), IIB (14), IIIB (3) and IVA (3). Two techniques were used: retroperitoneoscopy (RPS) in 16 cases, and a panoramic retroperitoneal pelviscopy (PRPP) in 36 cases. Results: Intra-operative and post-surgical morbidity were equivalent in the two procedures. Among the 33 patients who had external irradiation, one Grade 3 urinary late morbidity (3%) due to an overtreatment was observed; no Grade 3/4 morbidity of the gastro-intestinal tract, no lymphoedema of the lower extremities, no parietal tumor cells implantation were noticed. Conclusions: These procedures can be used safely to better know the prognosis and to define the pelvic lymph node planning target volume and its radiation management with accuracy.
引用
收藏
页码:233 / 239
页数:7
相关论文
共 27 条
[1]  
[Anonymous], 1989, ENVAHISSEMENT GANGLI
[2]  
Bartel M, 1969, Zentralbl Chir, V94, P377
[3]  
BOLLA M, 1990, Journal de Gynecologie Obstetrique et biologie de la Reproduction, V19, P187
[4]  
BOLLA M, 1979, B CANCER, V66, P525
[5]  
BOLLA M, 1993, B CANC RADIOTHER, V80, P59
[6]  
BOLLA M, 1993, JOB GYN, V1, P407
[7]  
DARGENT D, 1993, JOB GYN, V1, P353
[8]  
DARGENT D, 1993, JOBGYN, V1, P39
[9]  
DAUPLAT J, 1992, CAH ONCOL, V1, P241
[10]  
GIRAUD B, 1993, B CANCER, V80, P17